�������

Today, �����о��� hosted a virtual press conference with the company’s in-space manufacturing and science team, the Saudi Space Commission, and select principal investigators representing the more than 20 different experiments that will be conducted during Axiom Mission 2 (Ax-2).

During the press conference, leaders highlighted the science research, technology demonstrations, and in-space manufacturing projects that will occur on the mission, as well as touched upon Axiom Station and the future of in-space solutions. The speakers included:

• Dr. Lucie Low, Chief Scientist, �����о���
• Jana Stoudemire, Director of In-Space Manufacturing, �����о���  
• Mishaal Ashemimry, Microgravity Research Lead, Saudi Space Agency
• Mari Anne Snow, Chief Executive Office, Eascra Biotech
• Dr. Clive Svendsen, Executive Director of Regenerative Medicine Institute, Cedars-Sinai
• Dr. Catriona Jamieson, Director, Sanford Stem Cell Clinical Center at UC San Diego Health
• Dr. Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine
• Dava Newman, Director, MIT Media Lab

Ax-2 is now targeted to launch to the International Space Station NET May 8 at 10:43 p.m. EDT aboard a SpaceX Dragon spacecraft from Launch Complex 39A at NASA’s Kennedy Space Center in Florida.

‍